Reference
Peeters H, et al. Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. Acta Gastroenterologica Belgica 81: 15-21, No. 1, Jan-Mar 2018. Available from: URL: https://www.ncbi.nlm.nih.gov/pubmed/29562373 - Belgium
Rights and permissions
About this article
Cite this article
Adalimumab/infliximab. Reactions Weekly 1701, 15 (2018). https://doi.org/10.1007/s40278-018-45847-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45847-7